Skip to main content
Vivatmo for Doctors
Cost-effective data enhancement

Vivatmo: FeNO for Clinical Studies

FeNO is a well-established biomarker for asthma. Not only doctors and patients, but also clinical researchers and Contract Research Organizations (CROs) can greatly benefit from FeNO home measurement with the Vivatmo system from Bosch.

An asthma patient discusses her FeNO values with their pulmonologist from the comfort of their own home via webcam.

FeNO Home Monitoring – Benefits for Clinical Studies

The Vivatmo system from Bosch provides simple and precise FeNO measurement in medical practices and at home. Clinical researchers and CROs conducting studies with FeNO benefit from Vivatmo home monitoring:

Cost reduction

Lower the cost of data collection, such as reducing on-site visits and device costs.

More data over time

Capture more FeNO values during the given observation period while maintaining high data quality.

Boost clinical insights

Enrich data with app-recorded context information and raise clinical insights to the next level.

Joy of Use: Higher Adherence, Fewer Drop-Outs

Vivatmo me is the world’s first device approved for FeNO home monitoring. Together with the Vivatmo app, it makes home testing quick, easy, and highly reliable. The system guides users step by step, making incorrect measurements virtually impossible. Readings are automatically transmitted via Bluetooth to the Vivatmo app or to third-party systems such as a CRO’s study app. Patients can also log relevant data such as symptoms, medication, or well-being. The workflow is designed to make FeNO home monitoring simple and joyful, promoting high adherence and providing study teams with complete, reliable datasets.

Woman performing FeNO test at home with Vivatmo me
The FeNO@home study confirmed excellent usability, high adherence, and physician satisfaction (Beeh et al. 2025).
FeNO measurement performance with App Guidance
App Guidance: With the latest app update (expected end of 2025), real-time guidance now provides immediate feedback on exhalation flow – too soft, too strong, or just right – making the maneuver even more intuitive.
SDK Integration of Vivatmo in clinical studies
An optional Software Development Kit (SDK) allows seamless integration of FeNO data into external applications and study platforms, supporting streamlined trial workflows.
/
Infographic showcasing the various benefits that Contract Research Organizations gain from home measurements.

The Vivatmo System for Clinical Studies

The Vivatmo system is ideally suited for conducting clinical studies. It consists of two devices: Vivatmo pro, the FeNO measurement device for use in study centers. And Vivatmo me, the world’s only FeNO home measurement device for patients. The FeNO values measured at home are transferred via Bluetooth either to the Vivatmo app or to any third-party app using the Software Development Kit (SDK). The Vivatmo app offers the export of reports (CSV or PDF) to obtain an overview of all relevant data.

Comparison of the Vivatmo me and Vivatmo pro devices: The Vivatmo pro is designed for measurements in study centers, while the Vivatmo me is intended for use in patients' homes.
The Vivatmo system consists of two devices: Vivatmo pro – for FeNO testing in practice or clinic. Vivatmo me (incl. optional Vivatmo app) – for FeNO home monitoring.
Statistical overview of daily monitored FeNO measurements over the timespan of one month
The Vivatmo app's monthly report provides a comprehensive overview of FeNO levels, medications, symptoms, pollen counts, and other relevant contextual data critical to optimizing asthma therapy.
/

Benefits of the Vivatmo System

Descriptive graphic illustrating the components of the Vivatmo me device
Precision made in Germany

Bosch sensor technology

Vivatmo is an exceptionally cost-efficient system requiring no recalibration, maintenance, or sensor exchange during the entire lifetime – due to high-precision Bosch technology made in Germany.

Patient measures her FeNO values using the Vivatmo me
Quick and easy testing

High adherence

In the FeNO@home study, both doctors and patients confirmed the excellent usability, high adherence, and therapeutic benefits of Vivatmo me. It allows easy and non-invasive FeNO measurement to obtain objective and reliable data.

Doctor explains a patient her FeNO measurement values using the Vivatmo base station
App & SDK

Seamless integration

Vivatmo me allows easy Bluetooth transfer of FeNO values from the Vivatmo device to the Vivatmo app. FeNO values can also be transferred to third-party apps, such as those from Contract Research Organizations (CRO), using our SDK.

Vivatmo test results shown on the vivatmo app
Data management

Single source collection

The Vivatmo app collects FeNO values and contextual data in a single source, allowing this data to be easily transferred to CRO databases for streamlined data processing.

Want to try Vivatmo in studies?
Contact us for more information via email!
Get summary now!
Download flyer for researchers and CROs (PDF)

Easy Integration of FeNO and Context Data

Vivatmo streamlines data integration for clinical researchers and CROs. It enables easy consolidation of data from study centers and home monitoring into a central study database. The Vivatmo app and SDK facilitate transmission of FeNO values and context data from home monitoring to the researcher's database. For easy integration with healthcare IT systems, Vivatmo pro offers an HL7 and a GDT standard-based interface. This eliminates the need for manual data entry and reduces potential errors.

Infographic illustrating various data sources for the study database. Vivatmo pro transmits the FeNO value and medical records, while Vivatmo me provides the FeNO value and context data
Summary of the key facts of the FeNO@home study.
FeNO@home study

Clinical benefits and practicality of FeNO home monitoring

FeNO is a recognized biomarker for Type 2 inflammation in asthma. While doctor's measurements are included in guidelines, the additional benefits of home monitoring have been less clear. The FeNO@home study published in 2024 sheds new light on this crucial aspect of asthma management.

Explore FeNO@home study

More Information

References

Beeh et al. 2025: Device adherence and user experience with daily home-based FeNO monitoring (Vivatmo me) in asthmatics: the FeNO@home observational study. BMC Digital Health 2025: Usability assessed via User Experience Questionnaire Plus: Patients rated usability in several categories on a scale from –3 (very poor) to +3 (excellent). The median UEQ+ score was 2.05. Adherence measured as the proportion of study days with at least one FeNO measurement. The median Proportion of Days Covered (PDC) across all patients was 93%. Physicians rated expectation fulfilment on a scale from 0 (not at all) to 6 (absolutely); 87% of responses were 5 or 6. DOI: 10.1186/s44247-025-00212-1

This website contains general product information about the Vivatmo system from Bosch. Not all products and their functions mentioned here are approved in every regional market. For a detailed description of the products and features as well as information on intended and safe use, please refer to your locally authorized Bosch distribution partner and the instructions for use that are valid for your country.